Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study
This study has been completed.
Sponsor:
Bispebjerg Hospital
Information provided by:
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT00206895
First received: September 12, 2005
Last updated: October 10, 2006
Last verified: October 2004
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to evaluated the efficacy and tolerability of methyl aminolevulinate and 5-aminolevulinic acid photodynamic therapy in patients with moderate to severe facial acne vulgaris in a randomized controlled and investigator blinded trial.
| Condition | Intervention |
|---|---|
|
Acne Vulgaris |
Procedure: Photodynamic therapy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind Primary Purpose: Treatment |
Resource links provided by NLM:
Further study details as provided by Bispebjerg Hospital:
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
Criteria
Inclusion Criteria:18 years or older, good health, more than 12 inflammatory facial acne lesions -
Exclusion Criteria:skin type VI, pregnant or lactating woman. Oral retinoid use within one year, systemic antibiotics within 1 month, topical acne treatment within 2 weeks.
-
Contacts and Locations
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00206895 History of Changes |
| Other Study ID Numbers: | KF-01-177/04 |
| Study First Received: | September 12, 2005 |
| Last Updated: | October 10, 2006 |
| Health Authority: | Denmark: The Ministry of the Interior and Health |
Additional relevant MeSH terms:
|
Acne Vulgaris Acneiform Eruptions Skin Diseases Facial Dermatoses Sebaceous Gland Diseases |
ClinicalTrials.gov processed this record on May 23, 2013